Evidence map›Paper›PMID 35842428›Full record

ArticleNature communications2022

The CIP2A-TOPBP1 complex safeguards chromosomal stability during mitosis.

Mara De Marco Zompit, Mònica Torres Esteban, Clémence Mooser, Salomé Adam, Silvia Emma Rossi, Alain Jeanrenaud, Pia-Amata Leimbacher, Daniel Fink, Ann-Marie K Shorrocks, Andrew N Blackford and 2 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
4.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 3 countries.

Mara De Marco ZompitDepartment of Gynecology, University of Zurich and University Hospital Zurich, Schlieren, Switzerland.
Mònica Torres EstebanDepartment of Gynecology, University of Zurich and University Hospital Zurich, Schlieren, Switzerland.
Clémence MooserDepartment of Gynecology, University of Zurich and University Hospital Zurich, Schlieren, Switzerland.
Salomé AdamLunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON, Canada.
Silvia Emma RossiLunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON, Canada.
Alain JeanrenaudDepartment of Gynecology, University of Zurich and University Hospital Zurich, Schlieren, Switzerland.
Pia-Amata LeimbacherDepartment of Gynecology, University of Zurich and University Hospital Zurich, Schlieren, Switzerland.
Daniel FinkDepartment of Gynecology, University of Zurich and University Hospital Zurich, Schlieren, Switzerland.
Ann-Marie K ShorrocksDepartment of Oncology, MRC Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK.ORCID 0000-0003-4844-1721
Andrew N BlackfordDepartment of Oncology, MRC Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK.ORCID 0000-0003-1979-021X
Daniel DurocherLunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON, Canada.ORCID 0000-0003-3863-8635
Manuel StuckiDepartment of Gynecology, University of Zurich and University Hospital Zurich, Schlieren, Switzerland. manuel.stucki@uzh.ch.ORCID 0000-0002-9974-0134
University of Zurich · CHMount Sinai Hospital · CAJohn Radcliffe Hospital · GB

Funding

Cancer Research UK 20772Cancer Research UK C29215/A20772Medical Research Council MR/N013468/1
6 · The paper itself

Abstract

The accurate repair of DNA double-strand breaks (DSBs), highly toxic DNA lesions, is crucial for genome integrity and is tightly regulated during the cell cycle. In mitosis, cells inactivate DSB repair in favor of a tethering mechanism that stabilizes broken chromosomes until they are repaired in the subsequent cell cycle phases. How this is achieved mechanistically is not yet understood, but the adaptor protein TOPBP1 is critically implicated in this process. Here, we identify CIP2A as a TOPBP1-interacting protein that regulates TOPBP1 localization specifically in mitosis. Cells lacking CIP2A display increased radio-sensitivity, micronuclei formation and chromosomal instability. CIP2A is actively exported from the cell nucleus in interphase but, upon nuclear envelope breakdown at the onset of mitosis, gains access to chromatin where it forms a complex with MDC1 and TOPBP1 to promote TOPBP1 recruitment to sites of mitotic DSBs. Collectively, our data uncover CIP2A-TOPBP1 as a mitosis-specific genome maintenance complex.

Indexed as

AutoantigensCarrier ProteinsDNA-Binding ProteinsDNA RepairIntracellular Signaling Peptides and ProteinsMembrane ProteinsNuclear ProteinsCell Cycle ProteinsChromosomal InstabilityDNAHumansMitosisAutoantigensCarrier ProteinsCell Cycle ProteinsCIP2A protein, humanDNADNA-Binding ProteinsIntracellular Signaling Peptides and ProteinsMembrane ProteinsNuclear ProteinsTOPBP1 protein, human

Identifiers

PMID35842428
PMCPMC9288427
OpenAlexW4285587584

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.